Mesoblast (MESO) Cash from Operations: 2015-2023
Historic Cash from Operations for Mesoblast (MESO) over the last 7 years, with Jun 2023 value amounting to -$16.3 million.
- Mesoblast's Cash from Operations fell 17.16% to -$16.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$63.3 million, marking a year-over-year increase of 3.82%. This contributed to the annual value of -$50.0 million for FY2025, which is 3.18% down from last year.
- Mesoblast's Cash from Operations amounted to -$16.3 million in Q2 2023, which was down 0.17% from -$16.2 million recorded in Q1 2023.
- In the past 5 years, Mesoblast's Cash from Operations ranged from a high of -$1.3 million in Q4 2019 and a low of -$30.6 million during Q4 2020.
- Over the past 3 years, Mesoblast's median Cash from Operations value was -$16.4 million (recorded in 2022), while the average stood at -$17.2 million.
- As far as peak fluctuations go, Mesoblast's Cash from Operations plummeted by 2,199.25% in 2020, and later soared by 40.42% in 2021.
- Mesoblast's Cash from Operations (Quarterly) stood at -$1.3 million in 2019, then crashed by 2,199.25% to -$30.6 million in 2020, then surged by 40.42% to -$18.2 million in 2021, then grew by 9.69% to -$16.5 million in 2022, then fell by 17.16% to -$16.3 million in 2023.
- Its last three reported values are -$16.3 million in Q2 2023, -$16.2 million for Q1 2023, and -$16.5 million during Q4 2022.